Creato da XagenaMedicina il 15/10/2009

Xagena Medicina

Discussione di argomenti medico-farmacologici

 

« Drugs NewsletterCardiology Newsletter »

Neurology Newsletter

Neurology - NeurologyOnline.net
 
NeurologyOnline.net, Neurology Xagena, Newsletter Xagena, Neurologia Xagena, Aggiornamento in Medicina,  Xagena News, Medicine AZ , Newsletter Neurology, Neurology News,
Neurology Newsletter, Parkinson Newsletter, Alzheimer Newsletter, Drugs in Neurology Newsletter, Multiple sclerosis Newsletter, Headache Newsletter, Insomnia Newsletter, Migraine Newsletter 
 
Alpha-synuclein
Higher levels of alpha-synuclein reverse symptoms in Parkinson ...
benefits in ON-time, OFF-time ...
Further long-term Safinamide use in these ... in motor function ...
Cholinesterase inhibitors
Efficacy and adverse effects of cholinesterase inhibitors and ...
Acetylsalicylic acid
A randomized trial showed that Aspirin ( Acetylsalicylic acid ) is ...
Aubagio
Teriflunomide ( Aubagio ) is a once-daily oral immunomodulator ...
Copaxone
Search results for "Copaxone" ... Sclerosis, provided evidence ...
No clinical benefit of ...
The proportion of patients with a ... no clinical benefit of ...
Dimethyl fumarate
Tecfidera for the treatment of adult patients with relapsing remitting ...
Safinamide as add-on to ...
Safinamide as add-on to Levodopa in mid to late ...
Cocaine
Cocaine addiction: molecular ... Cocaine might increase their ...

 
 
 
Vai alla Home Page del blog
RSS (Really simple syndication) Feed Atom
 

AREA PERSONALE

 

ARCHIVIO MESSAGGI

 
 << Maggio 2024 >> 
 
LuMaMeGiVeSaDo
 
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    
 
 

CERCA IN QUESTO BLOG

  Trova
 

FACEBOOK

 
 

FACEBOOK

 
 
Citazioni nei Blog Amici: 54
 

ULTIME VISITE AL BLOG

a_solitary_manprefazione09Alfa_Beta416161m12ps12acer.250Desert.69XagenaMedicinatiberis1santiago.gamboadony686marabertowiltuocognatino1cassetta2ilmondodiisidejonas21
 

CHI PUÒ SCRIVERE SUL BLOG

Solo l'autore può pubblicare messaggi in questo Blog e tutti gli utenti registrati possono pubblicare commenti.
I messaggi e i commenti sono moderati dall'autore del blog, verranno verificati e pubblicati a sua discrezione.
 
RSS (Really simple syndication) Feed Atom
 
 
 
 

© Italiaonline S.p.A. 2024Direzione e coordinamento di Libero Acquisition S.á r.l.P. IVA 03970540963